Principal Financial Group »

Intra Cellular Therapies shares owned by Principal Financial Group

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Principal Financial Group from 13F filings

Historical chart of Principal Financial Group investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Principal Financial Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $37M 527k 69.20
2023-12-31 $33M 461k 71.60
2023-09-30 $22M 416k 52.50
2023-06-30 $27M 418k 63.32
2023-03-31 $1.3M 23k 54.15
2022-12-31 $1.3M 25k 52.92
2022-09-30 $2.1M 46k 46.56
2022-06-30 $11M 192k 57.08
2022-03-31 $4.0M 66k 61.19
2021-12-31 $3.5M 67k 52.34
2021-09-30 $1.2M 31k 37.29
2021-06-30 $1.2M 30k 40.85
2021-03-31 $835k 25k 33.91
2020-12-31 $728k 23k 31.80
2020-09-30 $353k 14k 25.63
2020-06-30 $359k 14k 25.70
2019-12-31 $276k 8.1k 34.27
2015-12-31 $247k 4.6k 53.68